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Abstract: Two types of porous ceramic scaffolds were prepared, consisting of β-tricalcium phosphate (TCP) or the mixed 
powder of TCP and hydroxyapatite (HA) at a 2:1 mass ratio. A variety of methods have been used to fabricate bone scaf-
folds, while the sintering approach was adopted in this work. An extremely high temperature was used on sintering that 
proposed to consolidate the ceramic particles. As revealed by SEM, a well opened pore structure was developed within 
the scaffolds. The θ-values were measured to be of 73.3° and 6.5° for the composite scaffold and TCP sample, respec-
tively. According to XRD patterns, the existence of grains coalescence and partial bonding between HA and TCP powders 
was demonstrated. Scaffold mechanical property in the term of flexural strength was also determined. The result showed 
decreasing of the strength by HA supplement, suggesting the more brittle characteristic of HA in comparison with TCP. 
By soaking the composite scaffold in PBS for a period of 2 weeks, transformation from particles to flank-like crystalline 
was clearly observed. Such change was found to be favorable for cell attachment, migration, and growth. By implanting 
cell-seeded scaffolds into nude mice, an abundant osseous extracellular matrix was identified for the composite implants. 
In contrast, the matrix was minimally detected in TCP implanted samples. Thus, the composite scaffold was found supe-
rior for hard tissue regeneration.  
Keywords: Bone scaffold, hard tissue engineering, hydroxyapatite, β-tricalcium phosphate, osteoconductive. 
INTRODUCTION 
Bone is a remarkable organ playing critical functions in 
human physiology including protection, movement and sup-
port of other critical organs, blood production, mineral stor-
age and homeostasis, blood pH regulation, multiple progeni-
tor cells housing, and other [1]. The importance of bone be-
comes  clear  in  the  case  of  diseases  such  as  osteoarthritis, 
osteomyelitis, and osteoporosis where bone does not func-
tion  properly  [2].  Along  with  traumatic  injury,  orthopedic 
surgery, and tumor resection, these lead to or induce bone 
defects or voids of which bone replacement is typically re-
quired. Autologous bone grafting is the gold standard in re-
constructive  surgery  owing  to  high  immunocompatibility. 
However, the concept is bound by several constraints relat-
ing to requirement of secondary surgery, limited amount of 
tissue that can be harvested, as well as increased risk of in-
fection or recurrent pain [3]. To overcome these problems, 
tissue  engineering  approaches  are  emerging  as  convenient 
alternatives to promote the regenerative ability of the host 
body [4,5].  
One of the most important stages of bone tissue engineer-
ing is the design and processing of a porous, biodegradable 
3D structure called a scaffold. The scaffolds should provide  
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structural support for cells and newly formed tissues by act-
ing as a temporary extracellular matrix for natural processes 
of  tissue  regeneration  and  development.  In  the  meantime, 
they should degrade at  a rate comparable with new tissue 
growth [5]. Porosity is one of physical parameters for scaf-
folds necessary to be determined, since it provides adequate 
space  for  cell  migration  and  expansion,  and  maintains  the 
transport of nutrients and waste products [6,7]. In general, 
the interconnected pores of 100 µm diameter are considered 
as  a  minimum  requirement  [8,9].  Therefore,  the  improve-
ment  of  biological  activity  and  performance  of  bone-
substitute materials and scaffolds is one of the major con-
cerns in bone regeneration [10].  
A variety of biomaterials have been shown to help repair 
or replace damaged bone tissue. Each has its strengths and 
weaknesses,  and  no  one  has  been  demonstrated  to  stand 
above the rest. Opportunities thus exist for the discovery of 
the  best  possible  material  to  use  [11].  Bioactive  ceramics 
such as hydroxyapatite (HA), tricalcium phosphate (TCP), or 
the combination of them have drawn interest for hard tissue 
regeneration owing to their structural and chemical similarity 
with the inorganic component of bone [12]. These materials 
are osteoconductive because of exhibiting the capability to 
bond with bone and soft tissue, and stimulating bone growth 
[13].  HA  demonstrates  greater  hydrophobic  property,  and 
possesses lower resorption rate than TCP. There have been 
advantageous  in  pairing  HA  with  TCP,  as  some  designed 
parameters such as degradability and surface characteristics 
of the engineered scaffold have been improved [14]. In addi-280    The Open Biomedical Engineering Journal, 2010, Volume 4  Wongwitwichot et al. 
tion,  mechanical  strength and fracture toughness of HA  is 
ameliorated when a secondary phase of  low melting point 
bioceramic was added on sintering [15]. 
Two promising approaches generally applied in bone tis-
sue  engineering  to  address  the  challenging  requirements 
listed above include cell and acellular transplantations [16]. 
In  the  first  strategy,  mesenchymal  stem  cells  (MSCs)  are 
isolated from the patient, expanded ex vivo, seeded onto a 
scaffold and allowed to produce extracellular matrix (ECM) 
on the scaffold in controlled culture conditions, and finally 
implanted into osseous defect or void in the patient. In the 
second  approach,  however,  a  scaffold  without  cells  is  im-
planted  immediately  after  injury/bone  removal.  MSCs  are 
pluripotent cells capable of differentiation into a number of 
cell types. Also, they can be driven towards bone forming 
cells or osteoblasts which produce ECM within the scaffold 
ex  vivo. In many preclinical trials, transplantation of scaf-
folds  seeded  with  MSCs  has  been  shown  to  enhance  os-
teogenic capacity by integrating with native tissue faster than 
acellular scaffolds [17]. Despite indicating significant poten-
tial in bone tissue engineering, a primary obstacle in translat-
ing the first technique from the bench to the bedside is that 
the patient must wait for the bone graft to develop in vitro. 
Therefore, the ex vivo culture is generally supplemented with 
suitable  osteoinductive  factors,  intending  to  promote  rapid 
development of a ready-transplant cellular scaffold [18].  
In this work, scaffolds with newly designed-TCP based 
ceramics were developed. The impacts of HA on structural 
and surface properties, as well as on mechanical strength of 
the scaffolds were determined. Moreover, the osteoconduc-
tive capacity of the fabricated scaffolds was evaluated in vivo 
in nude mice.  
MATERIALS AND METHODS 
Fabrication of TCP or HA/TCP Scaffolds 
HA and TCP powders with the respective mean particle 
sizes of 7.9 and 4.7 µm were purchased from Sigma-Aldrich. 
The sieved sucrose particles (400-600 µm in diameter) were 
mixed with TCP or TCP plus HA using electric mixer. The 
procedure for fabricating scaffolds was schematically illus-
trated in Fig. (1). The mass ratio of inorganic substance(s) to 
sucrose  was  set  constantly  at  9:1.  Two  types  of  scaffolds 
were prepared: HT63 and T80. HT63 was consisted of HA, 
TCP and sucrose at a mass ratio of 6:3:1, while T80 con-
tained TCP and sucrose at 9:1 ratio by mass. Polyvinyl alco-
hol (15% w/v) was used as a binder in wet mixing. The mix-
ture was casted into a glass mould, cut into an optimal size, 
and dried at 37 °C for 3 days. The dried sample was pressed 
in  a  mould  using  hydraulic  pressing  apparatus.  Scaffold 
samples were heated at 500 °C for 4 h, and sintered at 1230 °C 
for 4 h. The heating rate of 15 °C per minute was used in 
both steps.  
Physical Characterization of the Prepared Scaffolds 
Scanning Electron Microscope (SEM) (Quanta 400, FEI, 
Czech Republic) was used to characterize surface morphol-
ogy, pore shape and size, and pore distribution of the fabri-
cated scaffolds after gold coating.  
Hydrophilic/hydrophobic  property  of  the  scaffold  sur-
faces  was  determined  by  measuring  the  contact  angle  (θ, 
OCA15+,  Data-physics,  Germany).  The  θ  is  the  angle  at 
which a liquid/vapor interface meets the solid surface. If the 
angle θ is less than 90°, the liquid is said to wet the solid. If 
it is greater than 90°, it is said to be non-wetting. A zero con-
tact angle represents complete wetting. If the liquid is water, 
the lesser θ means more hydrophilic of the solid surface.  
Crystal structure and phase composition of scaffold sam-
ples were detected using X-ray diffractometer. It was oper-
ated with Cu Kα radiation (λ = 0.154 nm) (X’Pert Pro MPD, 
Philips,  The  Netherlands),  scanning  in  a  continuous  mode 
from 30°-80° with a scanning rate of 2°/min.  
The flexural strength of the resulting products (25 mm x 
60  mm  x  9  mm  in  dimensions)  was  determined  by  using 
LLOYD  Compressive  Tester  equipped  with  a  100  N  load 
cell.  The  cross-head  speed  was  set  at  10  mm/min.  The 
strength was  calculated from the maximum load recorded. 
Three  samples  were  tested  for  each  condition.  Data  were 
analyzed  statistically  using  Student  t  test  and  significance 
was considered at p < 0.05. 
Soaking the Scaffolds in Phosphate Buffer Saline (PBS) 
pH 7.4 
The PBS solution was prepared by dissolving 80 g NaCl, 
2 g KCl, 14.4 g Na2HPO4 and 2.4 g KH2PO4 in a liter of 
water, and adjusted to pH 7.4 [19]. Triplicate samples from 
each group of the scaffolds were immersed in 20 ml of PBS 
for  2  weeks  at  37  °C  without  stirring.  After  removal,  the 
sample was gently washed with deionized water, and dried at 
room  temperature.  The  corresponding  non-immersed 
scaffold was served as the control. SEM was performed to 
examine surface characteristics of the scaffolds before and 
after soaking.  
 
Fig. (1). Schematic demonstration of the procedure used to fabri-
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Preparation  of  Marrow  Stromal  Cells  for  Seeding  on 
Scaffolds 
Culturing of Bone Stem Cells 
Bone marrow cells of human origin were kindly obtained 
from Dr. Leong Chooi Fun (Department of Physiology, Fac-
ulty  of  Medicine,  Universiti  Kebangsaan  Malaysia,  Kuala 
Lumpur).  Ficoll-plaque
TM  PLUS  (Amersham  Biosciences) 
was  used  in  isolation  of  primary  mesenchymal  cells  (P0) 
from the whole marrow cells. The undifferentiated P0 line 
was cultured on a 25 cm
2-flask (Nunc
®) using Dulbecco’s 
modified  Eagle  medium-F12  (DMEM-F12)  supplemented 
with  10%  fetal  bovine  serum  (FBS),  and  1%  penicil-
lin/streptomycin/amphotericin B at 37 °C in 5% carbon diox-
ide. The medium was changed  every 2-3 days. All of the 
culture media and chemicals were purchased from Gibco.  
Differentiation of P0 into Preosteoblasts 
The  osteogenic  induction  conditions  used  in  this  study 
were in according to our previously described method [18]. 
Briefly, the P0 cells (60% confluence) were starved in basal 
medium  (DMEM-F12  plus  1%  FBS,  and  1%  penicil-
lin/streptomycin/amphotericin B) for 12 h at 37 °C in 5% 
carbon dioxide. The medium was changed to serum free me-
dium (SFM) on the day of induction. The  cells were  then 
challenged  by  2.5  ng/ml  FGF2  (Merck  Biosciences,  Ger-
many) for 24 h, and left in basal medium for next 2 days. 
This was followed by changing the culture medium to SFM, 
and the addition of 10 ng/ml BMP2 (BioVision, USA). The 
cells were cultured in the presence of BMP2 for another 24 h 
before harvesting.  
Seeding of Preosteoblasts onto Scaffolds 
At the end of the induction period,  the  cell  monolayer 
was washed twice with PBS. The differentiated cells were 
scraped  from  the  cultured  flask,  and  dispersed  in  a  small 
volume of PBS. The scaffolds were submerged in 70% etha-
nol  for  12  h  for  sterilization,  and  soaked  several  times  in 
PBS to remove ethanol. The sterilized scaffolds were placed 
on tissue culture plates (6-cm diameter), and seeded with a 
100-µl cell suspension containing approximately of 10
7 dif-
ferentiated cells. The seeded scaffolds were incubated at 37 °C 
in 5% CO2 for 1 h to allow cell attachment.  
Implantation of the Seeded Scaffolds in Nude Mice 
Two-month-old nude mice (MF1) were kept in controlled 
environment, cared for and treated regarding to the institu-
tional guidelines (The ethic approval no. FF-253-2009, Fac-
ulty  of  Medicine,  Universiti  Kebangsaan  Malaysia).  The 
animals were anesthetized intramuscularly by the mixture of 
Xylazine  (25  mg/ml),  Ketamine  (25  mg/ml),  and  Zoletil 
(12.5 mg/ml) at 1:1:1 volume ratio with a 100-µl volume per 
25 g body weight. The seeded scaffolds were implanted on 
the back of the mice. The experiment was performed on trip-
licate  mice,  each  carrying  the  duplicate  of  three  sample 
types: HT63, T80 and BD (Fig. 2). Control scaffolds, called 
BD, were purchased from BD Bioscience in a sterilized form 
of rigid, preformed calcium phosphate. They were manipu-
lated using similar manners as described for the tested scaf-
folds. The animals were killed 4 weeks after implantation. 
The grafts were then removed and processed for histological 
analysis. 
Histological Analysis 
The implanted grafts were fixed overnight in 10% for-
maldehyde in PBS and decalcified for 3-4 h in 8% HCl satu-
rated with EDTA. The resulting grafts were paraffin embed-
ded, sectioned (5-µm thickness), and stained with hematox-
ylin-eosin (HE) or alizarin red S. For each sample, at least 
two different section levels and two histological sections for 
each level were analyzed. 
RESULTS  
Morphology of the Tested Scaffolds 
SEM images of the prepared scaffolds and the commer-
cial product were demonstrated in Fig. (3). An opened pore 
structure was developed in both types of the fabricated scaf-
folds  (3A  and  3B).  A  denser  microstructure  with  smaller 
pore size (15 ± 3 µm) was revealed by HT63 composites, 
whereas larger pores of 43 ± 8 µm diameter were formed in 
T80 scaffolds. According to “The product  manual” of  BD 
Bioscience,  the  pore  diameter  of  BD  scaffolds  ranged  be-
tween  200  and  400  µm  (Fig.  3C).  A  homogeneous  phase 
inside  the  composite  scaffolds  (HT63)  was  observed,  but 
grain  boundary  was  generally  apparent  in  TCP  samples 
(T80). Thus, the pore structure was changed by adding HA 
into TCP scaffold base. The removal of polyvinyl alcohol at 
high temperatures provided interconnected porous structure 
with porosity of approximately 40%, as demonstrated in Fig. 
(3A and 3B).  
Contact Angle (θ) 
Surface  hydrophilic/hydrophobic  property  was  deter-
mined by using water contact angle (θ). Results revealed that 
the θ-values of HT63 and T80 samples were of 73.3° ± 2.9° 
and 6.5° ± 0.3°, respectively. Increased surface hydrophobic-
ity was obtained by the addition of HA into TCP base  in 
which  the  consequence  was  dependent  on  the  amounts  of 
HA added (results not shown). 
XRD Analysis 
The XRD patterns of TCP powders and the compounded 
HA/TCP (at 2:1 ratio by mass) were represented in Fig. (4). 
 
Fig. (2). Implantation of the seeded scaffolds on the back of nude 
mice. There were triplicate mice taken in the surgical experiment. 
Each carrying the duplicate of three scaffold types: HT63, T80 and 
BD (the control). 282    The Open Biomedical Engineering Journal, 2010, Volume 4  Wongwitwichot et al. 
It was obvious to see a few merged peaks of the HA/TCP 
hybrid, which was in contrast to the separated peaks of TCP 
sample. The result indicated an occurrence of new composite 
upon  prolonged  heating  the  mixed  ceramics  at  extremely 
high temperature.  
The Flexural Strength 
The mechanical property of the scaffolds was measured 
in the term of flexural strength. The strength was calculated 
to be of 64.5 ± 1.8 MPa for T80 samples, and of 25 ± 1.2 MPa 
for  HT63  scaffolds.  Thus,  decreasing  of  the  strength  was 
responsible to HA addition, and was estimated to be due to 
the more brittle property and the higher melting point of HA. 
Soaking the Scaffolds in PBS 
The responses of HT63 composite and T80 scaffold in 
contact with PBS pH 7.4 were analyzed using SEM. SEM 
micrographs of the scaffolds before and after submerging in 
PBS at 37 °C for a period of 2 weeks were depicted in Fig. 
(5). Before soaking, the surfaces of both scaffold types were 
fully  covered  with  the  ceramic  particles  (Fig.  5A).  After 
soaking, a huge change in surface morphology was evident 
for the composite scaffold, as plentiful apatite-like deposits 
were observed on its surface (Fig. 5B). This result was in 
contrast to that revealed by T80 samples in that a sole in-
creasing of porosity within the scaffold structure was dem-
onstrated (Fig. 5C). 
Histological Observations 
The  pre-induced  MSCs  (see  Materials  and  Methods) 
were seeded onto the tested scaffolds: HT63, T80, and the 
control BD. Then, cell-loaded scaffolds were implanted on 
the back of nude mice. The implants were processed for his-
tological  analysis  4  weeks  later.  Results  indicated  that  a 
number  of  cells  infiltrated  into  BD  scaffolds  (Fig.  6A). 
However,  the  scaffold  matrices  were  vastly  filled  with  fi-
brous tissue instead of newly formed bone tissue (Fig. 6D). 
 
Fig. (3). SEM images of the fabricated scaffolds (A and B) and the commercial product from BD Bioscience (C). A: HT63, composed the 
combination of HA and TCP at a 2:1 mass ratio; B: T80, prepared by using pure TCP; C: the scaffold called BD, being the calcium phos-
phate based structure obtained from BD Bioscience. 
 
Fig. (5). SEM micrographs of HT63 composite before (A) and after (B) immerged in PBS pH 7.4 at 37 °C for 2 weeks. The image of T80 
scaffold  before  soaking  was  similar  to  that  revealed  by  the  composite  scaffold  (A),  thus  was  not  shown  here.  The  internal  structure/  
morphology of the submerged T80 showed increasing of porosity (C). 
 
Fig. (4). XRD patterns of TCP powder () and the mixture of HA 
and TCP at a mass ratio of 2:1 (---). Several separated peaks were 
observed for TCP sample, whereas a few merged peaks were ap-
parent for the composite as marked by asterisks.  Comparison of TCP and TCP/HA Hybrid Scaffolds  The Open Biomedical Engineering Journal, 2010, Volume 4    283 
Interestingly, clusters of new bone tissue were observed for 
HT63 implants. The clusters were surrounded by a numbers 
of  osteoblasts,  indicating  active  bone  formation  inside  the 
scaffolds (Fig. 6B). An abundant osseous extracellular ma-
trix was identified by alizarin red S staining (Fig. 6E). In the 
contrary, little regenerated bone cells were found in T80 im-
planted  samples  (Fig.  6C).  The  matrix  was  insignificantly 
detected, mostly around the outermost region (Fig. 6F). As 
indicated  in  Fig.  (6B  and  6C),  parts  of  scaffold  materials 
remained to be un-degradable within a period of 4 weeks of 
implantation.  
DISCUSSION 
This study was carried out to fabricate a bone scaffold 
with high mechanical strength and excellent biocompatibil-
ity. The porous HA has attached mush attention as bone sub-
stitutes because of its ability to lead osteoconduction. How-
ever, one of the main drawbacks for real applications is its 
poor  mechanical  property.  To  overcome  this  problem,  the 
combination of HA and a secondary phase bioceramic with 
lower melting point such as TCP was derived.  
Among many fabrication methods, the sintering approach 
was adopted in this work in which an extremely high tem-
perature  (1230  °C)  was  used  to  consolidate  HA  particles. 
The  method  was  found  to  be  quite  effective  in  obtaining 
highly porous structure. In addition, the minimal degradation 
of HA and the maximum level of strength of the resulting 
scaffolds was compromised. In fact, the sinter-ability of in-
organic powders is strictly related to the starting morphology 
and chemical composition. The presence of volatile moieties, 
as water and carbonate, is an obstacle to powder densifica-
tion  and  can  provoke  cracks  and  bubbles  [20].  Therefore, 
prolonged heating at a low temperature of 500 °C was effec-
tive in yielding the resistant bioceramics. The composite of 
HA/TCP also exhibited high mechanical strength, consisting 
with the result of previous study [21]. At the temperature of 
sintering, the grains of HA and TCP were coalesced, obtain-
ing a homogeneous composite as characterized by SEM (Fig. 
3A).  The  interconnected  pores  within  scaffold  structures 
were  introduced,  as  sucrose  and  the  binder  were  removed 
upon heat treatment. By using 10% w/w sucrose, the poros-
ity of about 40% was measurable (Fig. 3A and 3B). It was 
possible to change the porosity, just by increasing the sugar 
content  on  the  preparation  of  dry  mixtures.  However,  the 
products’  mechanical  strength  was  decreased,  accountable 
for increasing the porosity (results not shown), and be be-




Fig. (6). Photomicrographs of the implanted sections at magnification x100 for HE staining (A-C), and x40 for alizarin red S staining (D-F). 
The MSCs were sequentially induced with 2.5 ng/ml FGF2 and 10 ng/ml BMP2 (see Materials and Methods). The differentiated cells were 
ectopically implanted in nude mice following adsorbed on the tested scaffolds: BD (A and D); HT63 (B and E); and T80 (C and F). Symbols: 
, newly formed bone tissue; , osteoblasts lining around new bone formed; ✰, the remaining scaffold material; , new mineralized tissues. 284    The Open Biomedical Engineering Journal, 2010, Volume 4  Wongwitwichot et al. 
A denser microstructure with smaller pore size (15 ± 3 
µm) was revealed by HA/TCP composites (Fig. 3A). In con-
trast, the microstructure of TCP scaffolds was more loosened 
with wider pore diameter of 43 ± 8 µm (Fig. 3B). The results 
suggested  coalescing  of  the  ceramic  grains,  as  decreased 
residual porosity was taken place [20]. In compared to HA, 
the  mechanical  strength  of  the  scaffolds  consisting  of  HA 
and TCP was improved, while the property was deteriorated 
regarding to pure TCP (results not shown). This was due to 
the more brittle characteristic of the former bioceramic. By 
the current formulation and processing, mechanical problems 
usually encountered for load bearing applications was over-
come.  In  addition,  the  porous  and  opened  pore  structures 
were  assumed  to  be  used  in  segmental  bone  defects  [22]. 
Surface hydrophilicity was clearly affected by HA i.e., the 
decreasing was proportional to the amounts of HA supple-
mented in the combination (data not shown). The resulting 
hybrid scaffold demonstrated suitable physical and mechani-
cal properties, drawing interest towards the in vivo investiga-
tion for its competency. 
The ability of particular materials to serve as a scaffold 
on which bone cells can attach, proliferate, and be mineral-
ized  is  called  osteoconduction  [5].  The  prepared  scaffolds 
were tested for such the property in nude mice in comparison 
with  the  controls,  BD.  Before  seeding  onto  the  scaffolds, 
human MSCs were prior induced with a growth stimulation 
factor, FGF2, and subsequently with a differentiation factor, 
BMP2 [18]. The seeded scaffolds were then ectopically im-
planted  on  the  back  of  nude  mice  for  which  histological 
analysis was performed 4 weeks later. By aiming to evaluate 
early  histological  changes,  the  relatively  short  time  period 
was  limited  for  this  work.  There  were  no  phagocytes  ob-
served  in  the  tissue  sections  (Fig.  6A-C),  suggesting  that 
bacterial  infection  and  tissue  inflammation  did  not  take 
place, and that the implanted materials were biocompatible 
[22]. For HA/TCP  implants,  they were filled with  a well-
established layer of bony tissue (Fig. 6B) with abundant os-
seous extracellular matrices (Fig. 6E). However, little new 
bone was detected for TCP implants (Fig. 6C and 6F). In-
deed, the extracellular matrices of the control scaffolds were 
mostly filled with fibrous tissue (Fig. 6A and C). Thus, the 
osteoconductive activity was significantly distinct among the 
tested scaffolds in which the highest activity was revealed by 
the  composite  bioceramics.  The  appropriate  micro-
environmental  conditions  seemed  to  be  established  on  the 
surfaces of HA/TCP scaffold in vivo [23]. Fig. (5B) demon-
strated the formation of apatite-like crystals on HA/TCP sur-
faces after soaking in PBS for 2 weeks (Fig. 5B), whereas 
that of TCP samples was not visualized (Fig. 5C). This was 
supposed to associate with the partial dissolution of calcium 
phosphate crystals by which the super-saturation of calcium 
and phosphate ions in the microenvironment was generated. 
Then,  the  precipitation  of  carbonate  hydroxyapatite  was 
emerged  by  incorporating  carbonate  and  magnesium  ions 
present in the biological fluid into actions [24]. In accorded 
with the previous studies [25-27], transformation from parti-
cles to flank-like crystalline in situ was more apparent for 
HA biomaterial. This change was favorable for cell attach-
ment, migration, and growth, and greatly affected the bioac-
tive  characteristics  of  HA/TCP  composite.  Moreover,  the 
porosity of porous TCP structures was increased after soak-
ing (Fig. 5C). This increment was estimated to exist in situ, 
influencing cell migration. As a result, by using the prepared 
scaffolds, newly formed bone tissues were detected at inner 
parts of the implants. Since pore diameters of the prepared 
scaffolds were lower than the requirement limit of 100 µm, it 
was possible to exclude them from testing trials early. Inter-
estingly, the results suggested that limited pore size was not 
be a major obstacle affecting osteoconductive activity of the 
engineered scaffolds. In helping with  the selected osteoin-
ductive factors, FGF2 and BMP2, the porous HA/TCP com-
posite  scaffolds  played  important  roles  in  facilitating  cell 
attachment and the retention of infiltrated cells, as well as 
promoting them to form new bone. Consequently, it would 
be applied for general use in hard tissue regeneration.  
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